Apimeds Pharmaceuticals US, Inc. (APUS)
4.60
-0.02
(-0.43%)
USD |
NYAM |
Oct 14, 10:12
Apimeds Pharmaceuticals US Price to Book Value : 0.0652 for Oct. 14, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 13, 2026 | 0.0655 |
| October 12, 2026 | 0.0737 |
| October 09, 2026 | 0.0712 |
| October 08, 2026 | 0.0781 |
| October 07, 2026 | 0.0999 |
| October 06, 2026 | 0.1011 |
| October 05, 2026 | 0.0651 |
| October 02, 2026 | 0.0456 |
| October 01, 2026 | 0.0581 |
| September 30, 2026 | 0.0709 |
| September 29, 2026 | 0.0712 |
| September 28, 2026 | 0.0906 |
| September 25, 2026 | 0.1028 |
| September 24, 2026 | 0.0698 |
| September 23, 2026 | 0.0325 |
| September 22, 2026 | 0.0262 |
| September 21, 2026 | 0.0237 |
| September 18, 2026 | 0.0251 |
| September 17, 2026 | 0.0237 |
| September 16, 2026 | 0.0227 |
| September 15, 2026 | 0.0233 |
| September 14, 2026 | 0.0296 |
| September 11, 2026 | 0.0298 |
| September 10, 2026 | 0.0308 |
| September 09, 2026 | 0.0325 |
| Date | Value |
|---|---|
| September 08, 2026 | 0.0326 |
| September 04, 2026 | 0.0343 |
| September 03, 2026 | 0.0356 |
| September 02, 2026 | 0.0373 |
| September 01, 2026 | 0.0502 |
| August 31, 2026 | 0.055 |
| August 28, 2026 | 0.0549 |
| August 27, 2026 | 0.056 |
| August 26, 2026 | 0.0652 |
| August 25, 2026 | 0.0705 |
| August 24, 2026 | 0.0673 |
| August 21, 2026 | 0.0686 |
| August 20, 2026 | 0.0622 |
| August 19, 2026 | 0.0622 |
| August 18, 2026 | 0.0567 |
| August 17, 2026 | 0.0607 |
| August 14, 2026 | 0.0645 |
| August 13, 2026 | 0.0666 |
| August 12, 2026 | 0.0661 |
| August 11, 2026 | 0.0656 |
| August 10, 2026 | 0.0601 |
| August 07, 2026 | 0.06 |
| August 06, 2026 | 0.0685 |
| August 05, 2026 | 0.0659 |
| August 04, 2026 | 0.0698 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.500 |
| Alnylam Pharmaceuticals, Inc. | 22.31 |
| Anika Therapeutics, Inc. | 1.985 |
| Savara, Inc. | 6.813 |
| Vericel Corp. | 5.531 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0001 |
| Price | 4.60 |
| Earnings Yield | -798.0% |
| Market Cap | 6.942M |
| PEGY Ratio | -0.0001 |